PrimeVigilance announces their next webinar which will be co-hosted by Pharmafocus and features speaker Dr. Cvijeta Bielen PrimeVigilance Medical Director. This session takes place on Thursday 15th of March, 2018 starting at 3 pm GMT (UK), 4 pm CET (Europe), 11 am EDT (US). Dr. Bielen will provide practical advice on the following hot topic: EVDAS outputs are available to MAHs – what now ?
Key topics covered in this webinar include:
• How to plan signaling frequency
• What sources of data need to be considered
• What best to focus on during signal detection vs. signal evaluation reviews
• The robust documentation of activities
Finally this webinar will focus on giving the listeners a comprehensive overview of all the new regulatory requirements for products on an additional monitoring list, and some last-minute additional requirements for other products that were not expected to be impacted by EVDAS during 2018.
The webinar will be followed by a Q&A session where you will be able to ask questions and receive direct feedback on key areas of uncertainty.
+44 (0)1483 307920
(+1) 781 703 5540
United Kingdom (Head Office)